Cargando…
Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167426/ https://www.ncbi.nlm.nih.gov/pubmed/34095546 http://dx.doi.org/10.1016/j.jctube.2021.100240 |
_version_ | 1783701688953077760 |
---|---|
author | Van Deun, Armand Decroo, Tom |
author_facet | Van Deun, Armand Decroo, Tom |
author_sort | Van Deun, Armand |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8167426 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-81674262021-06-05 Should treatment of low-level rifampicin mono-resistant tuberculosis be different? Van Deun, Armand Decroo, Tom J Clin Tuberc Other Mycobact Dis Article Elsevier 2021-04-28 /pmc/articles/PMC8167426/ /pubmed/34095546 http://dx.doi.org/10.1016/j.jctube.2021.100240 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Van Deun, Armand Decroo, Tom Should treatment of low-level rifampicin mono-resistant tuberculosis be different? |
title | Should treatment of low-level rifampicin mono-resistant tuberculosis be different? |
title_full | Should treatment of low-level rifampicin mono-resistant tuberculosis be different? |
title_fullStr | Should treatment of low-level rifampicin mono-resistant tuberculosis be different? |
title_full_unstemmed | Should treatment of low-level rifampicin mono-resistant tuberculosis be different? |
title_short | Should treatment of low-level rifampicin mono-resistant tuberculosis be different? |
title_sort | should treatment of low-level rifampicin mono-resistant tuberculosis be different? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167426/ https://www.ncbi.nlm.nih.gov/pubmed/34095546 http://dx.doi.org/10.1016/j.jctube.2021.100240 |
work_keys_str_mv | AT vandeunarmand shouldtreatmentoflowlevelrifampicinmonoresistanttuberculosisbedifferent AT decrootom shouldtreatmentoflowlevelrifampicinmonoresistanttuberculosisbedifferent |